Study at a glance
How do cells obtain vitamin D carried in blood?
Cells can access forms of vitamin D in different ways. One way is to take in forms that are not attached to proteins. Some cells can also take in vitamin D attached to a carrier protein. The available routes vary between tissues.
How do the kidneys recover vitamin D attached to a protein?
Specialised proteins on kidney cells help retrieve vitamin D together with its carrier protein from filtered fluid. Disrupting this system can cause forms of vitamin D to be lost in urine.
Does a blood vitamin D level show how much every tissue receives?
No. Delivery also depends on how cells in each tissue take in and process vitamin D. Studies of kidney, breast-derived cells, muscle cells and placental tissue show different parts of this system, but they do not establish one rule for how all organs take in vitamin D.
Read the full article below ↓Transport in blood is only the first half of delivery
Carrier binding determines how vitamin D metabolites circulate, but tissue delivery asks a different question: how does material leave that circulating reservoir and become available to a particular cell? A simple answer based only on total plasma concentration is inadequate. So is a universal rule based only on the unbound fraction.
For many steroid-like molecules, the free-versus-total vitamin D distinction provides an important starting point: unbound ligand can cross membranes more readily, while strong protein binding limits the immediately free concentration. Vitamin D physiology, however, contains well-established exceptions in which cells retrieve carrier-bound substrate through receptor-mediated uptake. The consequence is a tissue-specific delivery system rather than one universal access rule.
The kidney provides the clearest causal model
The renal proximal tubule is the strongest demonstration that DBP-bound 25-hydroxyvitamin D is not simply an inaccessible circulating reserve. DBP and its bound metabolite pass through glomerular filtration and are retrieved by the endocytic receptors cubilin and megalin. Experimental disruption of this pathway produces urinary loss of vitamin-D-binding protein and 25-hydroxyvitamin D, lower circulating vitamin D metabolites and disturbed vitamin D metabolism.
This is more than a binding observation. It establishes a physiological conservation mechanism: the kidney can reclaim a protein-bound vitamin D metabolite from tubular fluid and deliver it into proximal-tubule cells, preserving substrate that would otherwise be lost in urine.
Carrier-bound substrate can be accessible outside the kidney
Extra-renal studies show that the renal model is not the only possible route. A deeper treatment of cellular uptake of vitamin D metabolites examines in more detail the mechanisms by which carrier-bound substrate can become biologically useful. Human mammary-derived cells express megalin and cubilin, internalize DBP and show reduced 25-hydroxyvitamin-D-driven responses when endocytosis is inhibited. This supports a mechanism in which local cellular vitamin D metabolism can depend partly on receptor-mediated access to DBP-bound precursor.
Skeletal-muscle experiments likewise demonstrate uptake and retention of 25-hydroxyvitamin D in differentiated muscle cells together with DBP uptake and megalin-associated effects. These findings support the possibility of an extravascular retention pool. They do not establish that skeletal muscle is quantitatively the dominant human storage organ for 25-hydroxyvitamin D.
The placenta shows another specialised delivery environment
Human placental perfusion and explant studies provide a different physiological setting. Vitamin D and placental function provides the organ-specific context for this specialised interface. Placental tissue takes up 25-hydroxyvitamin D, metabolises it and regulates its movement within the fetoplacental unit. Endocytic inhibition changes uptake and downstream handling, supporting active cellular control rather than simple passive equilibration across the maternal-fetal interface.
The placenta is a specialised organ, so its behaviour cannot be projected onto every tissue. Its importance for the broader transport question is conceptual: tissue exposure can depend on local uptake machinery and metabolism as well as on the concentration measured in plasma.
Why neither extreme model is sufficient
The evidence therefore argues against two opposite simplifications. It is too strong to say that only freely circulating vitamin D metabolites can reach cells, because receptor-mediated uptake of carrier-bound substrate is causally established in the kidney and supported in selected extra-renal systems. It is equally too strong to say that megalin/cubilin-mediated uptake is the general mechanism for all tissues.
Tissue delivery is conditional. It depends on the circulating carrier-bound and free pools, the metabolite involved, local receptor expression, cell differentiation and tissue-specific metabolic machinery. DBP can simultaneously restrict the instantaneous free fraction, preserve a large circulating reservoir and provide bound substrate to cells equipped to retrieve it. Total concentration, free concentration and tissue exposure are therefore related measurements or states, but they are not interchangeable descriptions of vitamin D availability.
Primary evidence and publication details
Safadi FF et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest. 1999;103:239-251.
Nykjaer A et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D3. Proc Natl Acad Sci USA. 2001;98:13895-13900.
Rowling MJ, Kemmis CM, Taffany DA, Welsh J. Megalin-Mediated Endocytosis of Vitamin D Binding Protein Correlates with 25-Hydroxycholecalciferol Actions in Human Mammary Cells. J Nutr. 2006;136:2754-2759.
Abboud M et al. Evidence for a Specific Uptake and Retention Mechanism for 25-Hydroxyvitamin D (25OHD) in Skeletal Muscle Cells. Endocrinology. 2013;154:3022-3030.
Ashley B et al. Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit. eLife. 2022;11:e71094.
Related reading
Multiple genome analyses reveal key genes in Vitamin C and Vitamin D synthesis and transport pathways are shared
Vitamin C (VC) and vitamin D (VD) have been widely used as the dietary supplements and in treatment of diseases both independently and in combination.
Original paper ↗Read more →Vitamin D Transport Proteins
Explore how vitamin D transport proteins regulate circulation, buffering, tissue delivery, and availability, shaping cellular metabolism and system-level vitamin D physiology.
Read more →Cellular uptake and intracellular handling of vitamin D metabolites: Full Evidence Review
full evidence review of cellular vitamin D metabolite uptake, intracellular handling, megalin-mediated transport and differences between tissues.
Read more →Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure
Impaired mineral homeostasis and inflammation are hallmarks of chronic kidney disease (CKD), yet the underlying mechanisms of electrolyte regulation during CKD are still unclear.
Original paper ↗Read more →Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats
The candidate VDREs identified may respond to 1,25D3 via activation of the vitamin D receptor, although this remains to be investigated.
Original paper ↗Read more →Life-supporting functional kidney replacement by integration of embryonic metanephros-bladder composite tissue transplants
Novel transplantable organs need to be developed to address the global organ shortage.
Original paper ↗Read more →Organic Synthesis of New Secosteroids from Fucosterol, Its Intestinal Absorption by Caco-2 Cells, and Simulation of the Biological Activities of Vitamin D
We investigated the intestinal absorption of these compounds using Caco-2 cells cultured in Transwells and compared the results with vitamin D3, a representative secosteroid.
Original paper ↗Read more →Vascular calcification in skin and subcutaneous tissue in patients with chronic and end-stage kidney disease
We compared these samples to skin samples of a control cohort without CKD.
Original paper ↗Read more →Bone Turnover in Patients with Chronic Kidney Disease Stage 5D and Healthy Controls: a Quantitative [18F]Fluoride PET Study
We compared optimized quantitative [18F]fluoride PET/CT methods to the reference standard with arterial input function (AIF) to identify a clinically accessible method for evaluation of bone turnover in patients with CKD.
Original paper ↗Read more →Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study
The objective of this study is to evaluate the effect of oral sodium bicarbonate on circulating FGF23 levels in patients with CKD.
Original paper ↗Read more →Evaluation of Sarcopenia in Renal Transplant Recipients
The aim of the present study was to assess the prevalence of sarcopenia in renal transplant recipients (RTR) and to evaluate the demographic and metabolic risk factors associated with sarcopenia in these patients.
Original paper ↗Read more →Impact of Vitamin D Supplementation on Arterial Vasomotion, Stiffness and Endothelial Biomarkers in Chronic Kidney Disease Patients
Cardiovascular events are frequent and vascular endothelial function is abnormal in patients with chronic kidney disease (CKD).
Original paper ↗Read more →Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
Serum calcium, phosphate, alkaline phosphatase,parathyroid hormone, FGF-23, 25(OH)D, 1,25(OH)2D and Fractional excretion of phosphorous were assessed and compared between the two groups, using SPSS software.
Original paper ↗Read more →Interactions between Serum Vitamin D Levels and Vitamin D Receptor Gene FokI Polymorphisms for Renal Function in Patients with Type 2 Diabetes
We aimed to examine associations among serum 25-hydroxyvitamin D (25OHD) levels, 1,25-dihyroxyvitamin D (1,25OHD) levels, vitamin D receptor (VDR) polymorphisms, and renal function based on estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes.
Original paper ↗Read more →Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis
As there is no consensus on the optimal treatment for post-kidney transplant recipients (KTRs), we aimed to evaluate the efficacy and safety of bisphosphonate and its combined therapies.
Original paper ↗Read more →Physical Activity and Health-Related Quality of Life in Kidney Transplant Recipients: A Cross-Sectional Exploratory Study of Clinical and Inflammatory Parameters
The aim was to evaluate PA levels in KTRs and explore their associations with HRQoL, clinical characteristics, and biochemical and inflammatory markers.
Original paper ↗Read more →Positive association between serum calcium-phosphorus ratio and kidney stone prevalence: Analysis of NHANES data (2007 to 2020)
This study utilized data from the 2007 to 2020 National Health and Nutrition Examination Survey (NHANES), including a total of 34,122 participants.
Original paper ↗Read more →Regulation of HHLA2 expression in kidney cancer and myeloid cells
HHLA2 expression in A498 and 786-O ccRCC cell lines was examined in vitro and in subcutaneous tumor xenografts in NSG mice.
Original paper ↗Read more →The impact of a needs-oriented dental prophylaxis program on bacteremia after toothbrushing and systemic inflammation in children, adolescents, and young adults with chronic kidney disease
General prevalence of bacteremia after toothbrushing was 9.5% affecting 7 (26%) of the participants.
Original paper ↗Read more →Vitamin D and osteoporosis in chronic kidney disease
Osteoporotic fractures are common in patients with chronic kidney disease (CKD).
Original paper ↗Read more →Vitamin D receptor polymorphisms and bone health after kidney transplantation
We investigated the relationship between the polymorphisms of the vitamin D receptor ( VDR ) gene and bone diseases occurring after kidney transplantation.
Original paper ↗Read more →Original sources
Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein
Published in J Clin Invest (1999).
Publication details
Safadi FF et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest. 1999;103:239-251.
Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D3
Published in Proc Natl Acad Sci USA (2001).
Publication details
Nykjaer A et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D3. Proc Natl Acad Sci USA. 2001;98:13895-13900.
Megalin-Mediated Endocytosis of Vitamin D Binding Protein Correlates with 25-Hydroxycholecalciferol Actions in Human Mammary Cells
Published in J Nutr (2006).
Publication details
Rowling MJ, Kemmis CM, Taffany DA, Welsh J. Megalin-Mediated Endocytosis of Vitamin D Binding Protein Correlates with 25-Hydroxycholecalciferol Actions in Human Mammary Cells. J Nutr. 2006;136:2754-2759.
Evidence for a Specific Uptake and Retention Mechanism for 25-Hydroxyvitamin D (25OHD) in Skeletal Muscle Cells
Published in Endocrinology (2013).
Publication details
Abboud M et al. Evidence for a Specific Uptake and Retention Mechanism for 25-Hydroxyvitamin D (25OHD) in Skeletal Muscle Cells. Endocrinology. 2013;154:3022-3030.
Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit
Published in eLife (2022).
Publication details
Ashley B et al. Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit. eLife. 2022;11:e71094.